Geneos Wealth Management
HIMS icon

Geneos Wealth Management’s Hims & Hers Health HIMS Stock Holding History

Geneos Wealth Management’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$85.1K Buy
2,857
+61
+2% +$1.87K ﹤0.01% 1446
2026
Q2 		$96.9K Buy
2,796
+396
+17% +$10.6K ﹤0.01% 1220
2026
Q1 		$49.8K Buy
2,400
+200
+9% +$4.72K ﹤0.01% 1430
2025
Q4 		$71.4K Sell
2,200
-20
-0.9% -$857 ﹤0.01% 1268
2025
Q3 		$126K Buy
2,220
+1,190
+116% +$61K ﹤0.01% 1048
2025
Q2 		$51.3K Buy
1,030
+12
+1% +$542 ﹤0.01% 1555
2025
Q1 		$30.1K Buy
+1,018
New +$37.8K ﹤0.01% 1736
2022
Q2 		– Sell
-2,150
Closed -$11K – 2667
2022
Q1 		$11K Buy
+2,150
New +$10.6K ﹤0.01% 2046

Other funds holding HIMS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
State of Michigan Retirement System
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Geneos Wealth Management's HIMS Position: Q3 2026 in Review

Geneos Wealth Management increased its Hims & Hers Health (HIMS) stake by 2.2% in Q3 2026, buying an estimated $1.87K and bringing the position to 2,857 shares worth $85.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1446.

Geneos Wealth Management first reported a position in HIMS in Q1 2022 and has held it in 8 quarters since. The position peaked at $126K in Q3 2025. 270 funds tracked by Wall St. Rank hold HIMS as of Q3 2026.

  • Geneos Wealth Management held 2,857 shares of Hims & Hers Health worth $85.1K as of Q3 2026.
  • Geneos Wealth Management bought 61 Hims & Hers Health shares in Q3 2026, an estimated $1.87K.
  • Hims & Hers Health made up ﹤0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #1446 holding.
  • Geneos Wealth Management first reported a position in Hims & Hers Health in Q1 2022 and has held it in 8 quarters since.
  • Geneos Wealth Management's Hims & Hers Health position peaked at $126K in Q3 2025.
  • 270 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.